Mylotarg® Sensitivity (CD33)

The Mylotarg® Sensitivity (CD33) test contains 1 test with 3 biomarkers.

Campath®-1H (Alemtuzumab) is an antibody targeted to CD52, an antigen expressed on the surface of chronic lymphocytic cells. Drug sensitivity can be performed prior to the initiation of therapy to potentially avoid toxicity.
  • No Prescription Needed
  • Discounts up to 80%
  • Hundreds of Lab Tests Available

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Mylotarg Sensitivity CD33

Result:

Sample Description:

Viability:

Search by Zip Code

No Results Found

There are no results that match the search criteria submitted.
Please change the criteria and try again.